We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Breath Ketone Analyzer Accurately Detects Ketosis in Type 1 Diabetes

By LabMedica International staff writers
Posted on 30 Sep 2021
Print article
Image: The Ketonix Breath Ketone Analyzer may be considered as a non-invasive screening tool to rule out ketosis in adults with type 1 diabetes (Photo courtesy of Ketonix)
Image: The Ketonix Breath Ketone Analyzer may be considered as a non-invasive screening tool to rule out ketosis in adults with type 1 diabetes (Photo courtesy of Ketonix)
The presence of high levels of ketones in the bloodstream is a common complication of diabetes, which if left untreated can lead to ketoacidosis. Ketones build up when there is insufficient insulin to help fuel the body’s cells.

High levels of ketones are more common in people with type 1 diabetes (T1D) or people with advanced type 2 diabetes. The most accurate way of testing for ketones is to use a blood glucose meter which can test for ketones as well as blood glucose levels. Urine can be tested for ketone levels; however, the testing of urine means that the level is representative of the ketone levels up to a few hours ago.

Medical Scientists at the University of Colorado (Aurora, CO, USA) assessed the accuracy of a breath ketone analyzer to detect ketosis in adults and children with type 1 diabetes. They analyzed data from adults and children aged 6 years or older that had type 1 diabetes for at least a year. Participants were given a breath ketone analyzer (Ketonix, Varberg, Sweden) and a blood ketone meter (Precision Xtra, Abbott Diabetes Care, Alameda, CA, USA) to measure ketones for 90 days. For 90 days, participants were asked to check ketones at least once daily, if their blood glucose was more than 300 mg/dL, or if they were having diabetic ketoacidosis symptoms. Measurements taken in the morning were considered fasting measurements, whereas all others were considered non-fasting.

The investigators reported that a total of 500 measurements from 19 adults and children with type 1 diabetes were analyzed. There was a significant association between the breath ketone analyzer and blood ketone meter results in non-fasting adults, but not in children. In adults, a cut-off of 3.9 PPM on the breath ketone analyzer maximized the Youden Index with an AUC of 0.73. This cut-off for the breath ketone analyzer had 94.7% sensitivity and 54.2% specificity to detect ketosis (≥0.6 mmol/L in blood ketone meter).

Halis Kaan Akturk, MD, an Endocrinologist and senior author of the study, said, “We found that morning fasting results in adults can be falsely higher in some individuals. We also included some adults with type 1 diabetes using SGLT2 inhibitors that already have higher ketone levels at baseline. A breath ketone analyzer can be a good screening tool in patients that are at high risk for ketosis.”

The authors concluded that the breath ketone analyzer may be considered as a non-invasive screening tool to rule out ketosis in adults with type 1 diabetes. The study was published on August 27, 2021 in the Journal of Diabetes and its Complications.

Related Links:
University of Colorado
Ketonix
Abbott Diabetes Care


Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Magnetic Bead Separation Modules
MAG and HEATMAG
Anti-Cyclic Citrullinated Peptide Test
GPP-100 Anti-CCP Kit
Gold Member
Real-time PCR System
GentierX3 Series

Print article

Channels

Hematology

view channel
Image: The CAPILLARYS 3 DBS devices have received U.S. FDA 510(k) clearance (Photo courtesy of Sebia)

Next Generation Instrument Screens for Hemoglobin Disorders in Newborns

Hemoglobinopathies, the most widespread inherited conditions globally, affect about 7% of the population as carriers, with 2.7% of newborns being born with these conditions. The spectrum of clinical manifestations... Read more

Immunology

view channel
Image: Exosomes can be a promising biomarker for cellular rejection after organ transplant (Photo courtesy of Nicolas Primola/Shutterstock)

Diagnostic Blood Test for Cellular Rejection after Organ Transplant Could Replace Surgical Biopsies

Transplanted organs constantly face the risk of being rejected by the recipient's immune system which differentiates self from non-self using T cells and B cells. T cells are commonly associated with acute... Read more

Microbiology

view channel
Image: The ePlex system has been rebranded as the cobas eplex system (Photo courtesy of Roche)

Enhanced Rapid Syndromic Molecular Diagnostic Solution Detects Broad Range of Infectious Diseases

GenMark Diagnostics (Carlsbad, CA, USA), a member of the Roche Group (Basel, Switzerland), has rebranded its ePlex® system as the cobas eplex system. This rebranding under the globally renowned cobas name... Read more

Pathology

view channel
Image: The revolutionary autonomous blood draw technology is witnessing growing demands (Photo courtesy of Vitestro)

Robotic Blood Drawing Device to Revolutionize Sample Collection for Diagnostic Testing

Blood drawing is performed billions of times each year worldwide, playing a critical role in diagnostic procedures. Despite its importance, clinical laboratories are dealing with significant staff shortages,... Read more